Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Cash Flow-to-Debt Ratio
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Cash Flow-to-Debt Ratio of -0.18x as of September 2025, meaning its operating cash flow of CN¥-8.22 Million could theoretically repay 0% of its total liabilities (CN¥45.34 Million) in one year. See financial agility of Qinghai Spring Medicinal Resources Techn to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Qinghai Spring Medicinal Resources Technology Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see Qinghai Spring Medicinal Resources Techn cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Qinghai Spring Medicinal Resources Technology Co Ltd. Check how high is Qinghai Spring Medicinal Resources Techn's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.59x | CN¥-26.41 Million | CN¥44.87 Million | ▼ -193.1% |
| 2024 | 0.63x | CN¥80.97 Million | CN¥128.02 Million | ▲ +143.3% |
| 2023 | 0.26x | CN¥23.92 Million | CN¥91.99 Million | ▲ +121.5% |
| 2022 | -1.21x | CN¥-31.82 Million | CN¥26.30 Million | ▲ +47.7% |
| 2021 | -2.31x | CN¥-63.93 Million | CN¥27.64 Million | ▼ -306.8% |
| 2020 | -0.57x | CN¥-77.95 Million | CN¥137.08 Million | ▲ +95.2% |
| 2019 | -11.74x | CN¥-236.30 Million | CN¥20.14 Million | ▼ -236.1% |
| 2018 | -3.49x | CN¥-183.97 Million | CN¥52.68 Million | ▼ -514.2% |
| 2017 | 0.84x | CN¥95.74 Million | CN¥113.56 Million | ▼ -49.4% |
| 2016 | 1.67x | CN¥344.99 Million | CN¥206.95 Million | ▼ -29.0% |
| 2015 | 2.35x | CN¥832.17 Million | CN¥354.60 Million | ▲ +3049.9% |
| 2014 | -0.08x | CN¥-89.64 Million | CN¥1.13 Billion | ▼ -307.5% |
| 2013 | -0.02x | CN¥-28.09 Million | CN¥1.44 Billion | ▲ +94.7% |
| 2012 | -0.37x | CN¥-701.18 Million | CN¥1.90 Billion | ▼ -338.9% |
| 2011 | 0.15x | CN¥249.98 Million | CN¥1.62 Billion | ▲ +102.9% |
| 2010 | 0.08x | CN¥71.47 Million | CN¥938.58 Million | ▲ +2.2% |
| 2009 | 0.07x | CN¥39.16 Million | CN¥525.60 Million | ▲ +110.7% |
| 2008 | 0.04x | CN¥20.83 Million | CN¥589.02 Million | ▲ +257.7% |
| 2007 | 0.01x | CN¥7.00 Million | CN¥707.61 Million | ▼ -60.4% |
| 2006 | 0.02x | CN¥21.57 Million | CN¥863.38 Million | ▼ -83.9% |
| 2005 | 0.16x | CN¥162.12 Million | CN¥1.05 Billion | ▲ +461.1% |
| 2004 | 0.03x | CN¥33.83 Million | CN¥1.22 Billion | ▲ +1430.8% |
| 2003 | 0.00x | CN¥1.43 Million | CN¥789.85 Million | ▼ -95.2% |
| 2002 | 0.04x | CN¥15.54 Million | CN¥415.90 Million | ▲ +193.0% |
| 2001 | -0.04x | CN¥-10.64 Million | CN¥264.94 Million | ▼ -267.0% |
| 2000 | 0.02x | CN¥4.52 Million | CN¥187.91 Million | ▼ -95.6% |
| 1999 | 0.55x | CN¥70.28 Million | CN¥128.04 Million | — |